Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
- PMID: 34857503
- DOI: 10.1016/j.euo.2021.11.003
Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
Comment on
-
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review.Eur Urol Oncol. 2021 Dec;4(6):914-923. doi: 10.1016/j.euo.2021.10.005. Epub 2021 Nov 17. Eur Urol Oncol. 2021. PMID: 34801437
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
